The cost-effectiveness of screening lung cancer patients for targeted drug sensitivity markers. [electronic resource]
Producer: 20120516Description: 1100-6 p. digitalISSN:- 1532-1827
- Anaplastic Lymphoma Kinase
- Antineoplastic Agents -- pharmacology
- Biomarkers, Tumor -- antagonists & inhibitors
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Cost-Benefit Analysis
- Crizotinib
- Drug Resistance, Neoplasm
- Humans
- Lung Neoplasms -- drug therapy
- Models, Biological
- Molecular Targeted Therapy -- economics
- Precision Medicine -- economics
- Pyrazoles -- pharmacology
- Pyridines -- pharmacology
- Quality of Life
- Receptor Protein-Tyrosine Kinases -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.